SecBot SecBot
8-K ·Filed May 18, 2026

ASRT

Assertio Holdings, Inc.
BULLISH
Impact 8/10
Horizonweeks Processed5mo ago SEC0001104659-26-063064
8-K context-dependent: Items 8.01
Actionable Insight ▲ Bullish

Traders should expect ASRT shares to trade up toward the $23.50 offer price as arbitrageurs price in deal completion. Monitor for any competing bids, regulatory hurdles, or shareholder lawsuits that could delay or derail the transaction. The waiver of the note offer removes a potential overhang on the convertible notes.

DirectionBullish
Confidencehigh
Horizonweeks
Latest settled — T+20d
ASRT ▲ +0.77% at T+20d
LONG call ✓ call won +0.77% · α vs SPY -0.81% · entry $23.32 → $23.50
Next anchor: T+60d due 3mo ago
Entry = T+0 close
May 18, 2026
via day close
T+1d
+0.39%
call +0.39% · α +1.04%
$23.41
settled 5mo ago
T+5d
+0.60%
call +0.60% · α -1.02%
$23.46
settled 5mo ago
T+20d
+0.77%
call +0.77% · α -0.81%
$23.50
settled 4mo ago
T+60d
Pending
due 3mo ago

Price Chart

Loading chart...

Executive Summary

Assertio Holdings announced it has entered into a definitive merger agreement with Zydus Worldwide DMCC, under which Zydus will acquire all outstanding shares of Assertio common stock for $23.50 per share in cash via a tender offer. The offer price represents a substantial premium to the current market cap of ~$151M, and the transaction is expected to close subject to customary conditions. This is a transformative event that will take the company private.

Key Facts

  • Merger agreement with Zydus Worldwide DMCC at $23.50 per share in cash
  • Cash tender offer for all outstanding common stock commenced May 18, 2026
  • Offer price implies a significant premium to the $151M market cap
  • Parent waived requirement for concurrent note offer on the 6.50% Convertible Senior Notes due 2027
  • Merger will constitute a Fundamental Change under the indenture, triggering noteholder rights

Financial Impact

Acquisition at $23.50 per share in cash; total deal value not disclosed but based on market cap of $151M, the premium is substantial

share pricedilutiondebt

Risk Factors

  • Transaction may not close due to regulatory or antitrust issues
  • Shareholders may not tender sufficient shares
  • Competing bids could emerge but are unlikely given the definitive agreement
  • Litigation challenging the deal could delay closing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
60% bullish (10 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-063064
Document: 0001104659-26-063064-index-headers.html0001104659-26-063064
Document: 0001104659-26-063064-index.html0001104659-26-063064
Document: 0001104659-26-063064.txt0001104659-26-063064
10 reports for ASRT
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ASRT — sortable, filterable
TypeNow
Jul 7, 2026
15w ago
25-NSE
NEUTRAL ★ 5/10
—awaiting T+20——
Jun 26, 2026
17w ago
15-12G
NEUTRAL ★ 6/10
$23.50awaiting T+20——
Jun 18, 2026
18w ago
EFFECT
NEUTRAL ★ 5/10
$23.50awaiting T+20——
Jun 16, 2026
18w ago
8-K
BULLISH ★ 7/10
$23.50awaiting T+20——
May 18, 2026
23w ago
8-K
BULLISH ★ 8/10
$23.32 $23.50▲ +0.77%▼ −0.81%—
May 8, 2026
24w ago
8-K
NEUTRAL ★ 3/10
$22.50 $23.44▲ +4.18%▲ +4.15%—
May 5, 2026
24w ago
8-K
NEUTRAL ★ 3/10
$22.16 $23.45▲ +5.82%▲ +0.87%—
May 4, 2026
25w ago
8-K
BULLISH ★ 8/10
$21.61 $23.43▲ +8.42%▲ +2.78%—
Apr 29, 2026
25w ago
8-K
NEUTRAL ★ 3/10
$18.43 $23.44▲ +27.18%▲ +21.96%—
Apr 9, 2026
28w ago
8-K
BULLISH ★ 8/10
$18.02 $22.20▲ +23.20%▲ +15.63%—
Showing 10 of 10

US Market Status

Market Closed — Opens in 4h 18m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 18, 2026